PROVIDENCE, R.I., 11 de agosto de 2023 /PRNewswire/ — EpiVax Inc. anuncia la publicación de los resultados de una colaboración de investigación con la Administración de Alimentos y Medicamentos destinada a optimizar las evaluaciones de medicamentos genéricos. La investigación, iniciada…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.